1. Vioxx: an unequal partnership between safety and efficacy;Editorial;Lancet,2004
2. E-mails suggest Merck knew Vioxx's dangers at early stage;Matthew;Wall Street Journal,2004
3. Failing the public health—rofecoxib, Merck, and the FDA;Topol;N Engl J Med,2004